• 1
    Young JD-E, Peterson CGB, Venge P & Cohn ZA. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 1986;321:613615.
  • 2
    Venge P & Peterson CGB. Eosinophil biochemistry and killing mechanisms. In: MorleyJ, editor. Eosinophils in asthma. London: Academic Press, 1989:163177.
  • 3
    Dahl R. Early and late-phase reactions in bronchi and nose. In: MygindN, PipkornU, DahlR, editors. Rhinitis and asthma. Copenhagen: Munksgaard, 1990:203212.
  • 4
    Bousquet J, Chanez P & Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:10331039.
  • 5
    Djukanovic R, Wilson JW & Britten KM, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatic and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990;152:863871.
  • 6
    Adelroth E, Rosenhall L, Johansson S-A, Linden M & Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of anti-asthmatic treatment with budesonide and terbutaline. Am Rev Respir Dis 1990;142:9199.
  • 7
    Jeffrey PK, Godfrey RW & Adelroth E, et al. Effects of treatment on airway inflammation and thickening of reticular collagen in asthma: a quantitative light and electron microscopic study and correlation with BAL. In: Alderoth E, editor. Cells, mediators and mucosal inflammation in asthma. Umeå: Umeå University Medical Dissertations, 1990:5971.
  • 8
    Lodrup-Carlsen KC, Halvorsen R, Ahlstedt S & Carlsen K-H. Eosinophil cationic protein and tidal flow volume loops in children 0–2 years of age. Eur Respir J 1995;8:11481154.
  • 9
    Venge P, Henriksen J & Dahl R. Eosinophils in exercise induced asthma. J Allergy Clin Immunol 1991;88:699704.
  • 10
    Zimmerman B & Tsui F. Can the measurement of serum ECP be used to monitor treatment of childhood asthma with inhaled steroid. Allergy 1993;48:129132.
  • 11
    Juntunen-Backman K, Jarvinen P & Sorva R. Serum eosinophil cationic protein during treatment of asthma in children. J Allergy Clin Immunol 1993;92:3438.
  • 12
    Murayama N, Doi S & Inoue T, et al. Changes of lymphocyte activation markers and eosinophil cationic protein in peripheral blood of severe asthmatics by beclomethasone dipropionate inhalation therapy. J Allergy Clin Immunol 1997;99:361.
  • 13
    Sorva R, Metso T, Turpeinen M, Juntunen-Buckman K, Björkstén F & Haahtela T. Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children. Pediatr Allergy Immunol 1997;8:4550.
  • 14
    Noah TL, Henderson FW, Henry MM, Peden DB & Devlin RB. Nasal lavage cytokines in normal, allergic, and asthmatic school-age children. Am J Respir Crit Care Med 1995;152:12901296.
  • 15
    Klementsson H, Svensson C, Andersson M, Venge P, Pipkorn U & Persson CGA. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a week pollen season. Clin Exp Allergy 1991;21:705710.
  • 16
    Rak S, Löwhagen O & Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 1988;82:470480.
  • 17
    Svensson C, Andersson M, Persson GAC, Venge P, Alkner U & Pipkorn U. Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol 1990;85:828833.
  • 18
    D'Amato G, Liccardi G, Russo M, Saggese M & D'Amato M. Measurement of serum levels of eosinophil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietaria pollen (treated and untreated with specific immunotherapy). Allergy 1996;51:245250.
  • 19
    Bisgaard H, Gronborg H, Mygind N, Dahl R, Lindqvist N & Venge P. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide. J Allergy Clin Immunol 1990;85:891895.
  • 20
    Terada N, Konno A & Tokawa K. Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy. J Allergy Clin Immunol 1994;94:629642.
  • 21
    Satoh K, Iakagi I, Itoh H & Baba S. Study on eosinophil cationic protein (ECP) and arylsulfatase B in nasal secretion and sera from patients with nasal allergy. Nippon Jibiinkoka Gakkai Kaiho 1991;94:786793.
  • 22
    Rasp G, Thomas PA & Bujia J. Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum. Clin Exp Allergy 1994;24:11511156.
  • 23
    Durham SR, Gould HJ & Thienes CP, et al. Expression of ε germ-line transcripts and mRNA for the heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997;27:28992906.
  • 24
    KlenJan A, Godtheip T, Van Toornenenbergen AW & Fokkens WJ. Allergen binding to specific IgE in the nasal mucosa of allergic patients. J Allergy Clin Immunol 1997;99:515512.
  • 25
    Rajakulasingam K, Durham SR & O'Brien F, et al. Enhanced expression of high-affinity IgE receptor (Fc epsilon RI) alpha chain in human allergen-induced rhinitis with colocalization to mast cells, macrophages, eosinophils, and dendritic cells. J Allergy Clin Immunol 1997;100:7886.
  • 26
    Marcucci F & Sensi L. A new method for IgE detection nasal mucosa. Clin Exp Allergy 1989;19:157162.
  • 27
    Sensi LG, Seri A, Siracusa A, Pertici L & Marcucci F. Allergic rhinitis in children: effects of flunisolide and disodium cromoglycate on nasal eosinophil cationic protein. Clin Exp Allergy 1997;27:270276.
  • 28
    Sensi LG, Piacentini GL & Nobile E, et al. Changes in nasal specific IgE to mites after periods of allergen exposure-avoidance: a comparison with serum levels. Clin Exp Allergy 1994;24:377382.
  • 29
    Lozewic S, Gomez E, Clague J, Gatland D & Davies RJ. Allergen induced changes in the nasal mucous membrane in seasonal allergic rhinitis: effect of nedocromil sodium. J Allergy Clin Immunol 1990;85:125131.
  • 30
    Pipkorn U, Karlsson G & Enerback L. The cellular response of the human allergic mucosa to natural allergen exposure. J Allergy Clin immunol 1988;82:10421054.